Thanks. Was walking the dog when I read last night so jumped the gun when I read weekly sales charts. Apologies.
Regardless, still allows for ~$23,500
In weekly testing revenues if the average weekly sales continues at 7 million. Not that we'll have 100% of the market or anything but still pretty huge. And not to forget that's based on gram sales so any larger quantity purchase or discount purchase would steadily increase those numbers if we're at $300/test or if smaller than 10# lots are tested, the more testing required for edibles etc.
As Mary pointed out too that's not including consulting revs and is just Oregon numbers. Include the one Cali lab for now and the 11k per week starts to look like an pretty low estimation. Been waiting for this little drop for 2+ months.
My questions that bounce around in my head are:
With these kinds of revs, at what point do we just open the cash register to handle debt so to speak? One would think that's a possibility in the not too distant future
What would share retirement/reduction do for confidence and price?
Since steep hill wanted in publicly with pz** but it didn't work, what would a merger do for us if it were to occur?
Just my thoughts/opinions, and playing with a calculator.
I don't always go long, but when I do it's SGBY
Good luck everyone.
News 
Market Data 
Discover 
